Journal article

Publication year: 2020

Pages: 1271-1286

Journal: Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volume number: 63

Issue number: 10

ISSN: 1436-9990

eISSN: 1437-1588

DOI Link: https://doi.org/10.1007/s00103-020-03218-4

Publisher: Springer

Abstract: 
In February 2019, the fourth expert meeting on rapid diagnostic tests (RDTs) for sexually transmitted infections (STI) was held at the Robert Koch Institute (RKI) in Berlin. Novel technical developments and new aspects of RDT applications were discussed by representatives from the German STI Society (DSTIG); RKI; the Paul Ehrlich Institute; national reference centers for HIV, HBV, and HCV; and reference laboratories forChlamydia, gonococci, andTreponema pallidum. As a result of this meeting, we present a revision of the joint statement on STI diagnostics with RDTs from 2017. The Regulation (EU) 2017/746 of the European Parliament and of the Council on in vitro diagnostic medical devices became effective in May 2017 and includes more stringent regulatory requirements for RDTs, mainly concerning conformity of manufacturing processes and performance characteristics of class D in vitro diagnostics (detection of HIV, HBV, HCV, andT. pallidum). Some RDTs for HIV, HCV, andT. pallidumhave been evaluated in clinical studies and/or were WHO prequalified and may be used in low-threshold services. Among them are some HIV RDTs available and approved for self-testing. In addition, some HBV RDTs based on detection of HBs antigen (HBsAg) received WHO prequalification. However, false negative results may occur in samples with low HBsAg levels, as for instance in HIV-coinfected patients receiving antiretroviral therapy. ForChlamydia trachomatis(CT) andNeisseria gonorrhoeae(NG), antigen-based RDTs still do not allow reliable detection of infection. Only PCR-based CT/NG RDTs possess sufficient diagnostic accuracy to be used as point-of-care tests. Rapid PCR tests for NG, however, do not provide any information about antimicrobial resistance.

Harvard Citation style: Meyer, T., Eberle, J., Ross, R., Schuettler, C., Baier, M., Buder, S., et al. (2020) Rapid diagnosis of sexually transmitted infections Joint statement of DSTIG, RKI, and PEI, as well as the reference centers for HIV, HBV, and HCV and consulting laboratories forChlamydia, gonococci, andTreponema pallidum, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 63(10), pp. 1271-1286. https://doi.org/10.1007/s00103-020-03218-4

APA Citation style: Meyer, T., Eberle, J., Ross, R., Schuettler, C., Baier, M., Buder, S., Kohl, P., Muenstermann, D., Hagedorn, H., Nick, S., Jansen, K., Bremer, V., Mau, M., & Brockmeyer, N. (2020). Rapid diagnosis of sexually transmitted infections Joint statement of DSTIG, RKI, and PEI, as well as the reference centers for HIV, HBV, and HCV and consulting laboratories forChlamydia, gonococci, andTreponema pallidum. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 63(10), 1271-1286. https://doi.org/10.1007/s00103-020-03218-4